Point of Care Diagnostics Market

Point of Care Diagnostics Market by Product (Glucose, Infectious Disease (Hepatitis C, Influenza, Respiratory), Coagulation), Platform (Microfluidics, Immunoassays), Mode (Prescription & OTC), End-User (Hospitals, Home Care) - Global Forecast to 2024

Report Code: MD 2702 Nov, 2019, by marketsandmarkets.com
Updated date -

[189 Pages Report] The point-of-care diagnostics market is projected to reach USD 46.7 billion by 2024 from USD 28.5 billion in 2019, at a CAGR of 10.4%. Factors such as the high prevalence of infectious diseases in developing countries, increasing incidence of target conditions, growing government support, and rising preference for home healthcare across the globe are driving the growth of the market. However, product recalls, a lack of alignment with test results obtained from laboratories, stringent & time-consuming approval policies, and a reluctance to change existing diagnostic practices are expected to restrain market growth.

Point-of-Care Diagnostics market, by Region, 2022 (USD Billion)

By product, the glucose monitoring products segment is expected to dominate the POC diagnostics market in 2019

On the basis of product, the point-of-care diagnostics market is segmented into glucose monitoring, infectious disease testing, cardiometabolic monitoring, coagulation monitoring, hematology testing, urinalysis testing, cholesterol testing, drugs-of-abuse testing, tumor/cancer markers, pregnancy & fertility testing, fecal occult testing, and other POC products. The glucose monitoring products segment is expected to dominate the POC diagnostics market in 2019. The increasing number of POC glucose monitoring devices, coupled with the growing prevalence of diabetes, is expected to drive the growth of the POC diagnostics market for glucose monitoring products in the coming years.  

By platform, the lateral flow assays segment is expected to account for the largest share of the POC diagnostics market in 2019.

Based on platform, the point-of-care diagnostics market is segmented into lateral flow assays, immunoassays, molecular diagnostics, dipsticks, and microfluidics. In 2019, the lateral flow assays segment is expected to account for the largest share of the POC diagnostics market. The large share of this segment is attributed to the increasing adoption of lateral flow assays in POC testing as a replacement for lengthy, conventional laboratory procedures.  

By mode of purchase, the OTC products segment is expected to register the highest growth rate during the forecast period.

On the basis of mode of purchase, the market is segmented into prescription-based products and OTC products. The OTC products segment is expected to command the largest share of the market in 2019 and is projected to register the highest CAGR during the forecast period. The OTC products segment will register the highest growth during the forecast period, primarily due to the increasing adoption of OTC devices across the globe.

The home care settings segment is the fastest-growing end-user segment of the POC diagnostics market.

On the basis of end user, the point-of-care diagnostics market is segmented into clinical laboratories and outpatient healthcare & ambulatory care settings, hospitals/critical care centers, home care settings, and other end users. The home care settings segment is expected to grow at the highest CAGR during the forecast period. The high growth of this segment can be attributed to the increasing inclination towards home healthcare and rising demand for rapid tests among home care users.

North America is expected to account for the largest share of the POC diagnostics market in 2019.

The market, by region, is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America is expected to command the largest share of the POC diagnostics market in 2019, due to the growing prevalence of lifestyle diseases, increasing number of product approvals, and rising government initiatives in this region.

Point-of-Care Diagnostics market, by Region, 2022 (USD Billion)

Key Market Players

The major players operating in this market are Abbott (US), Roche (Switzerland), Siemens (Germany), Danaher (US), Becton, Dickinson and Company (US), Johnson & Johnson (US), Instrumentation Laboratory (US), PTS Diagnostics (US), Quidel (US), Chembio Diagnostic Systems (US), Sekisui Diagnostics (US), Nova (US), EKF Diagnostics (UK), AccuBioTech (China), and Trinity Biotech (Ireland).

Roche (Switzerland) is the leading player in the global point-of-care diagnostics market. The company focuses on developing new products and technologies in the field of diagnostics. In addition, the company has a strong global presence with manufacturing facilities in Europe and the US and strong distribution channels to serve markets in Europe, the Middle East, Africa, Asia Pacific, and Latin and North America.

Scope of the report

Report Metric

Details

Market Size Available for Years

2017–2024

Base Year Considered

2018

Forecast Period

2019 – 2024

Forecast Units

Value (USD)

Segments Covered

Product, Platform, Mode of Purchase, End User, and Region

Geographies Covered

North America (US & Canada), Europe (Germany, France, UK, and RoE), APAC (Japan, China, India, and RoAPAC), Latin America, and the Middle East & Africa

Companies Covered

15 major players covered, Roche Diagnostics (Switzerland), Abbott Laboratories (US), Siemens Healthineers (Germany), Becton, Dickinson and Company (US), Johnson & Johnson (US), Danaher Corporation (US), Chembio Diagnostic Systems (US), Quidel Corporation (US), EKF Diagnostics (UK), Trinity Biotech (Ireland), AccuBioTech (China), Nova Biomedical (US), PTS Diagnostics (US), Instrumentation Laboratory Company (US), and Sekisui Diagnostics (US).

This research report categorizes the market based on product, platform, mode of purchase, end user, and region.

Point-of-care Diagnostics Market, by Product

  • Glucose Monitoring Products
    • Strips
    • Meters
    • Lancets & Lancing Devices
  • Cardiometabolic Monitoring Products
    • Cardiac Marker Testing Products
    • Blood Gas/Electrolyte Testing Products
    • HbA1c Testing Products
  • Infectious Disease Testing Products
    • Influenza Testing Products
    • HIV Testing Products
    • Hepatitis C Testing Products
    • Sexually Transmitted Disease Testing Products
    • Healthcare-associated Infection Testing Products
    • Respiratory Infection Testing Products
    • Tropical Disease Testing Products
    • Other Infectious Disease Testing Products
  • Coagulation Monitoring Products
    • PT/INR Testing
    • ACT/APTT
  • Pregnancy & Fertility Testing Products
    • Pregnancy Testing Products
    • Fertility Testing Products
  • Tumor/Cancer Marker Testing Products
  • Urinalysis Testing Products
  • Cholesterol Testing Products
  • Hematology Testing Products
  • Drugs-of-abuse Testing Products
  • Fecal Occult Testing Products
  • Other POC Products

Point-of-care Diagnostics Market, by Platform

  • Lateral Flow Assays
  • Dipsticks
  • Microfluidics
  • Molecular Diagnostics
  • Immunoassays

Point-of-care Diagnostics Market, by Mode of Purchase

  • Prescription-based Products
  • OTC Products

Point-of-care Diagnostics Market, by End User

  • Clinical Laboratories and Outpatient Healthcare & Ambulatory Care Settings
  • Hospitals/Critical Care Centers
  • Home Care Settings
  • Other End Users

Point-of-care Diagnostics Market, by Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Rest of Europe (RoE)
  • Asia Pacific
    • Japan
    • China
    • India
    • Rest of Asia Pacific (RoAPAC)
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa

Recent Developments

  • In 2019, Abbott Laboratories (US) collaborated with Sanofi (France) to integrate glucose sensing and insulin delivery technologies.
  • In 2019, Chembio Diagnostic Systems (US) received approval from ANVISA for its DPP Zika/Dengue/Chikungunya/ System.
  • In 2019, Roche Diagnostics (Switzerland) launched its VENTANA PD-L1 (SP142), which can identify triple-negative breast cancer (TNBC) patients who are eligible for treatment with TECENTRIQ (atezolizumab).
  • In 2017, Abbott Laboratories (US) acquired Alere (US) to expand its global diagnostics presence and gain access to new geographies.
  • In 2017, Siemens Healthineers (Germany) acquired Fast Track Diagnostics (Luxembourg). This acquisition enabled the company to expand its diagnostics segment.

Key Questions Addressed by the Report:

  • What are the growth opportunities related to the adoption of point-of-care diagnostics across major regions in the future?
  • Emerging countries have immense opportunities for the growth and adoption of point-of-care diagnostics. Will this scenario continue in the next five years?
  • Where will all the advancements in products offered by various companies take the industry in the mid- to long-term?
  • What are the new trends and advancements in the market?

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Table of Contents

1 Introduction (Page No. - 19)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 22)
    2.1 Research Data
           2.1.1 Secondary Data
                    2.1.1.1 Key Data From Secondary Sources
           2.1.2 Primary Data
                    2.1.2.1 Key Data From Primary Sources
    2.2 Market Size Estimation
           2.2.1 Product-Based Market Estimation
           2.2.2 Market Size Estimation: Overall Market
           2.2.3 Primary Research Validation
    2.3 Market Breakdown and Data Triangulation
    2.4 Research Limitations & Assumptions
           2.4.1 Limitations
           2.4.2 Assumptions

3 Executive Summary (Page No. - 32)

4 Premium Insights (Page No. - 36)
    4.1 POC Diagnostics Market Overview
    4.2 Geographic Analysis: POC Diagnostics Market
    4.3 POC Diagnostics Market, By Product
    4.4 POC Diagnostics Market, By Prescription Mode
    4.5 Geographic Snapshot of the POC Diagnostics Market

5 Market Overview (Page No. - 40)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 High Prevalence of Infectious Diseases in Developing Countries
                    5.2.1.2 Increasing Incidence of Target Conditions
                    5.2.1.3 Growing Government Support
                    5.2.1.4 Shortage of Skilled Laboratory Technicians
                    5.2.1.5 Rising Number of Clia-Waived POC Tests
           5.2.2 Restraints
                    5.2.2.1 Pricing Pressure Owing to Reimbursement Cuts and Budget Constraints
                    5.2.2.2 Stringent and Time-Consuming Regulatory Policies
           5.2.3 Opportunities
                    5.2.3.1 Emerging Markets
                    5.2.3.2 Healthcare Decentralization—Converting Lab Tests to POC Tests
                    5.2.3.3 Increasing Awareness Through Conferences and Events
                    5.2.3.4 POC Tests With Multiplexing Capabilities
           5.2.4 Challenges
                    5.2.4.1 Lack of Alignment With Definitive Central Lab Methods
                    5.2.4.2 Inadequate Knowledge About the Use of POC Devices in Professional Settings
                    5.2.4.3 Reluctance to Change Existing Diagnostic Practices
                    5.2.4.4 High Cost of Devices
                    5.2.4.5 Product Recalls
           5.2.5 Emerging Applications of Point-Of-Care Testing
                    5.2.5.1 Sepsis Biomarkers
                    5.2.5.2 Stroke Markers
                    5.2.5.3 Thyroid Testing
                    5.2.5.4 Dna Testing
                    5.2.5.5 Endocrine Testing

6 Point-Of-Care Diagnostics Market, By Product (Page No. - 52)
    6.1 Introduction
    6.2 Glucose Monitoring Products
           6.2.1 Glucose Monitoring Products Account for the Largest Share of the POC Diagnostics Market
           6.2.2 Strips
           6.2.3 Meters
           6.2.4 Lancets & Lancing Devices
    6.3 Cardiometabolic Monitoring Products
           6.3.1 Cardiac Marker Testing Products
                    6.3.1.1 Rising Government Initiatives for Cvd Research Will Contribute to Market Growth
           6.3.2 Blood Gas/Electrolyte Testing Products
                    6.3.2.1 Technological Advancements in Blood Gas/Electrolytes Products Will Drive the Growth of This Market Segment
           6.3.3 Hba1c Testing Products
                    6.3.3.1 Government Initiatives are Promoting the Regular Use of Hba1c Testing
    6.4 Infectious Disease Testing Products
           6.4.1 Influenza Testing Products
                    6.4.1.1 Rising Influenza Prevalence has Driven Demand for Market Products
           6.4.2 Hiv Testing Products
                    6.4.2.1 Rising Prevalence of Hiv to Drive Market Growth
           6.4.3 Hepatitis C Testing Products
                    6.4.3.1 Central and East Asia are Among the Highly Affected Regions With Hepatitis C
           6.4.4 Sexually Transmitted Disease Testing Products
                    6.4.4.1 Privacy and Confidentiality Issues are the Key Factors Leading to the Adoption of POC Std Testing Products
           6.4.5 Healthcare-Associated Infection Testing Products
                    6.4.5.1 Rising Prevalence of Hais is the Key Factor Driving Market Growth
           6.4.6 Respiratory Infection Testing Products
                    6.4.6.1 POCt Products for the Diagnosis of Respiratory Infections Offer Lower Sensitivity as Compared to Other Tests
           6.4.7 Tropical Disease Testing Products
                    6.4.7.1 Increasing Government Funding for the Use of POC in Tropical Disease Testing Will Support Market Growth
           6.4.8 Other Infectious Disease Testing Products
    6.5 Coagulation Monitoring Products
           6.5.1 Pt/Inr Testing Products
                    6.5.1.1 Pt/Inr is One of the Most Commonly Used Coagulation Monitoring Methods
           6.5.2 Act/Aptt Testing Products
                    6.5.2.1 Rising Number of Patients Undergoing Angioplasty and Dialysis Globally are Driving Demand for Market Products
    6.6 Pregnancy & Fertility Testing Products
           6.6.1 Pregnancy Testing Products
                    6.6.1.1 Pregnancy Testing Will Account for A Larger Market Share Owing to the Rising Inclination Toward Home Testing
           6.6.2 Fertility Testing Products
                    6.6.2.1 Increasing Awareness of Fertility Testing to Drive Market Growth
    6.7 Tumor/Cancer Marker Testing Products
           6.7.1 Increasing Investments for Research Related to POC Cancer Testing are Driving Growth
    6.8 Urinalysis Testing Products
           6.8.1 Rising Prevalence of Urinary Tract Infections is Driving Market Growth
    6.9 Cholesterol Testing Products
           6.9.1 Rising Obesity Levels & Cardiovascular Disorder Incidence are the Key Factors Supporting Market Growth
    6.1 Hematology Testing Products
           6.10.1 Preference for Laboratory-Based Tests Among Users Will Impede Market Growth
    6.11 Drugs-Of-Abuse Testing Products
           6.11.1 Rising Consumption of Illicit Drugs has Boosted Demand for Testing
    6.12 Fecal Occult Testing Products
           6.12.1 Lack of Proper Training in the Use of Fecal Occult Testing Hampers Market Adoption
    6.13 Other POC Products

7 Point-Of-Care Diagnostics Market, By Platform (Page No. - 78)
    7.1 Introduction
    7.2 Lateral Flow Assays
           7.2.1 Technological Advancements and Increasing Adoption of Lfa are Supporting Market Growth
    7.3 Dipsticks
           7.3.1 Dipsticks Help in Routine Analysis of Several Medical Conditions
    7.4 Microfluidics
           7.4.1 Microfluidics is an Emerging Platform in POC Diagnostics
    7.5 Molecular Diagnostics
           7.5.1 Increasing Initiatives By Market Players for Developing POC Molecular Diagnostic Products to Drive Market Growth
    7.6 Immunoassays
           7.6.1 Rising Incidence of Cancer and Growing Awareness About Immunoassay Platforms to Support Market Growth

8 Point-Of-Care Diagnostics Market, By Mode of Purchase (Page No. - 83)
    8.1 Introduction
    8.2 Prescription-Based Products
           8.2.1 Growing Prevalence of Lifestyle Diseases and Favorable Reimbursement Have Driven Market Growth
    8.3 OTC Products
           8.3.1 Rising Focus on Home Care is Expected to Boost Demand for OTC Testing in the Coming Years

9 Point-Of-Care Diagnostics Market, By End User (Page No. - 87)
    9.1 Introduction
    9.2 Professional Diagnostic Centers
           9.2.1 Clinical Laboratories and Outpatient Healthcare & Ambulatory Care Settings
                    9.2.1.1 Rapid Result Generation and Availability of Immediate Patient Care are the Major Factors Driving the Growth of This End-User Segment
    9.3 Hospitals/Critical Care Centers
           9.3.1 Hospitals are Among the Largest End Users of POC Diagnostics
    9.4 Home Care Settings
           9.4.1 Increasing Inclination Towards Home Healthcare is Driving the Growth of This End-User Segment
    9.5 Research Laboratories
           9.5.1 Development of Highly Specialized POC Tests and the Increasing Adoption of POCt Devices to Support the Growth of This Segment
    9.6 Other End Users

10 Point-Of-Care Diagnostics Market, By Region (Page No. - 94)
     10.1 Introduction
     10.2 North America
             10.2.1 US
                        10.2.1.1 US Dominated the North American Market in 2019
             10.2.2 Canada
                        10.2.2.1 Rising Government Initiatives to Support the Growth of the POC Diagnostics Market in Canada
     10.3 Europe
             10.3.1 Germany
                        10.3.1.1 Germany Accounted for the Largest Share of the European Market
             10.3.2 France
                        10.3.2.1 Growing Public-Private Collaborations for Product Development to Drive Market Growth
             10.3.3 UK
                        10.3.3.1 Growing Awareness of the Benefits Offered By POC Diagnostics to Support Market Growth in the UK
             10.3.4 Rest of Europe
     10.4 Asia Pacific
             10.4.1 Japan
                        10.4.1.1 Japan Dominates the APAC POC Diagnostics Market
             10.4.2 China
                        10.4.2.1 Rising Investments By Market Players and the Chinese Government to Drive the Growth of the POC Diagnostics Market in China
             10.4.3 India
                        10.4.3.1 High Burden of Chronic Diseases to Support Market Growth
             10.4.4 Rest of Asia Pacific
     10.5 Rest of the World (RoW)
             10.5.1 Latin America
                        10.5.1.1 Increasing Prevalence of Infectious Diseases to Drive the Adoption of POC Diagnostics
             10.5.2 Middle East & Africa
                        10.5.2.1 Rising Prevalence of Cancer to Support Market Growth in the MEA

11 Competitive Landscape (Page No. - 133)
     11.1 Introduction
     11.2 Ranking of Players, 2018
     11.3 Competitive Scenario
             11.3.1 Product Launches, Enhancements, and Approvals
             11.3.2 Agreements, Partnerships, and Collaborations
             11.3.3 Acquisitions
     11.4 Vendor Dive Overview
     11.5 Vendor Inclusion Criteria
     11.6 Vendor Dive
             11.6.1 Visionary Leaders
             11.6.2 Innovators
             11.6.3 Dynamic Differentiators
             11.6.4 Emerging Companies

12 Company Profiles (Page No. - 138)
(Business Overview, Products Offered, Recent Developments, MnM View)* 
     12.1 Abbott Laboratories
     12.2 Becton, Dickinson, and Company (BD)
     12.3 Chembio Diagnostics
     12.4 Danaher Corporation
     12.5 Johnson & Johnson
     12.6 Roche Diagnostics (A Subsidiary of F. Hoffmann-La Roche Ltd.)
     12.7 Siemens Healthineers Group
     12.8 EKF Diagnostics
     12.9 Quidel
     12.1 Trinity Biotech
     12.11 Accubiotech
     12.12 Instrumentation Laboratory (A Werfen Company)
     12.13 Nova Biomedical
     12.14 PTS Diagnostics (A Part of Sinocare Inc.)
     12.15 Sekisui Diagnostics
*Business Overview, Products Offered, Recent Developments, MnM View Might Not Be Captured in Case of Unlisted Companies. 

13 Appendix (Page No. - 183)
     13.1 Discussion Guide
     13.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
     13.3 Author Details


List of Tables (99 Tables)

Table 1 Recent Waivers of Market Products
Table 2 Point-Of-Care Diagnostics Market, By Product, 2017–2024 (USD Million)
Table 3 Market for Glucose Monitoring Products, By Type, 2017–2024 (USD Million)
Table 4 Market for Glucose Monitoring Products, By Region, 2017–2024 (USD Million)
Table 5 Market for Cardiometabolic Monitoring Products, By Type, 2017–2024 (USD Million)
Table 6 Market for Cardiometabolic Monitoring Products, By Region, 2017–2024 (USD Million)
Table 7 Cardiac Marker Testing Products Market, By Region, 2017–2024 (USD Million)
Table 8 Blood Gas/Electrolyte Testing Products Market, By Region, 2017–2024 (USD Million)
Table 9 Hba1c Testing Products Market, By Region, 2017–2024 (USD Million)
Table 10 Market for Infectious Disease Testing Products, By Type, 2017–2024 (USD Million)
Table 11 Market for Infectious Disease Testing Products, By Region, 2017–2024 (USD Million)
Table 12 Market for Influenza Testing Products, By Region, 2017–2024 (USD Million)
Table 13 Hiv Testing Products Market, By Region, 2017–2024 (USD Million)
Table 14 Hepatitis C Testing Products Market, By Region, 2017–2024 (USD Million)
Table 15 Std Testing Products Market, By Region, 2017–2024 (USD Million)
Table 16 Healthcare-Associated Infection Testing Products Market, By Region, 2017–2024 (USD Million)
Table 17 Respiratory Infection Testing Products Market, By Region, 2017–2024 (USD Million)
Table 18 Tropical Disease Testing Products Market, By Region, 2017–2024 (USD Million)
Table 19 Other Infectious Disease Testing Products Market, By Region, 2017–2024 (USD Million)
Table 20 Market for Coagulation Monitoring Products, By Type, 2017–2024 (USD Million)
Table 21 Market for Coagulation Testing Products, By Region, 2017–2024 (USD Million)
Table 22 Pt/Inr Testing Products Market, By Region, 2017–2024 (USD Million)
Table 23 Act/Aptt Testing Products Market, By Region, 2017–2024 (USD Million)
Table 24 Market for Pregnancy & Fertility Testing Products, By Type, 2017–2024 (USD Million)
Table 25 Market for Pregnancy & Fertility Testing Products, By Region, 2017–2024 (USD Million)
Table 26 Pregnancy Testing Products Market, By Region, 2017–2024 (USD Million)
Table 27 Fertility Testing Products Market, By Region, 2017–2024 (USD Million)
Table 28 Market for Tumor/Cancer Marker Testing Products, By Region, 2017–2024 (USD Million)
Table 29 Market for Urinalysis Testing Products, By Region, 2017–2024 (USD Million)
Table 30 Market for Cholesterol Testing Products, By Region, 2017–2024 (USD Million)
Table 31 Market for Hematology Testing Products, By Region, 2017–2024 (USD Million)
Table 32 Market for Drugs-Of-Abuse Testing Products, By Region, 2017–2024 (USD Million)
Table 33 Market for Fecal Occult Testing Products, By Region, 2017–2024 (USD Million)
Table 34 Market for Other POC Products, By Region, 2017–2024 (USD Million)
Table 35 POC Diagnostics Market, By Platform, 2017–2024 (USD Million)
Table 36 Point-Of-Care Diagnostics Market, By Mode of Purchase, 2017–2024 (USD Million)
Table 37 Prescription-Based Products Market, By Region, 2017–2024 (USD Million)
Table 38 OTC Products Market, By Region, 2017–2024 (USD Million)
Table 39 Market, By End User, 2017–2024 (USD Million)
Table 40 Market for Professional Diagnostic Centers, By Type, 2017–2024 (USD Million)
Table 41 Market for Professional Diagnostic Centers, By Region, 2017–2024 (USD Million)
Table 42 Point-Of-Care Diagnostics Market for Clinical Laboratories and Outpatient Healthcare & Ambulatory Care Settings, By Region, 2017–2024 (USD Million)
Table 43 Market for Hospitals/Critical Care Centers, By Region, 2017–2024 (USD Million)
Table 44 Market for Home Care Settings, By Region, 2017–2024 (USD Million)
Table 45 Market for Research Laboratories, By Region, 2017–2024 (USD Million)
Table 46 Market for Other End Users, By Region, 2017–2024 (USD Million)
Table 47 Market, By Region, 2017–2024 (USD Million)
Table 48 North America: Market, By Country, 2017–2024 (USD Million)
Table 49 North America: Point-Of-Care Diagnostics Market, By Product, 2017–2024 (USD Million)
Table 50 North America: Market, By Mode of Purchase, 2017–2024 (USD Million)
Table 51 North America: Point-Of-Care Diagnostics Market, By End User, 2017–2024 (USD Million)
Table 52 US: Market, By Product, 2017–2024 (USD Million)
Table 53 US: Market, By Mode of Purchase, 2017–2024 (USD Million)
Table 54 US: Market, By End User, 2017–2024 (USD Million)
Table 55 Canada: Market, By Product, 2017–2024 (USD Million)
Table 56 Canada: Point-Of-Care Diagnostics Market, By Mode of Purchase, 2017–2024 (USD Million)
Table 57 Canada: Market, By End User, 2017–2024 (USD Million)
Table 58 Europe: Market, By Country, 2017–2024 (USD Million)
Table 59 Europe: Market, By Product, 2017–2024 (USD Million)
Table 60 Europe: Market, By Mode of Purchase, 2017–2024 (USD Million)
Table 61 Europe: Market, By End User, 2017–2024 (USD Million)
Table 62 Germany: Market, By Product, 2017–2024 (USD Million)
Table 63 Germany: Market, By Mode of Purchase, 2017–2024 (USD Million)
Table 64 Germany: Market, By End User, 2017–2024 (USD Million)
Table 65 France: Market, By Product, 2017–2024 (USD Million)
Table 66 France: Market, By Mode of Purchase, 2017–2024 (USD Million)
Table 67 France: Point-Of-Care Diagnostics Market, By End User, 2017–2024 (USD Million)
Table 68 UK: Market, By Product, 2017–2024 (USD Million)
Table 69 UK: Market, By Mode of Purchase, 2017–2024 (USD Million)
Table 70 UK: Market, By End User, 2017–2024 (USD Million)
Table 71 Roe: Market, By Product, 2017–2024 (USD Million)
Table 72 Roe: Market, By Mode of Purchase, 2017–2024 (USD Million)
Table 73 Roe: Point-Of-Care Diagnostics Market, By End User, 2017–2024 (USD Million)
Table 74 APAC: Market, By Country, 2017–2024 (USD Million)
Table 75 APAC: Market, By Product, 2017–2024 (USD Million)
Table 76 APAC: Market, By Mode of Purchase, 2017–2024 (USD Million)
Table 77 APAC: Market, By End User, 2017–2024 (USD Million)
Table 78 Japan: Market, By Product, 2017–2024 (USD Million)
Table 79 Japan: Market, By Mode of Purchase, 2017–2024 (USD Million)
Table 80 Japan: Market, By End User, 2017–2024 (USD Million)
Table 81 China: Market, By Product, 2017–2024 (USD Million)
Table 82 China: Point-Of-Care Diagnostics Market, By Mode of Purchase, 2017–2024 (USD Million)
Table 83 China: Market, By End User, 2017–2024 (USD Million)
Table 84 India: Market, By Product, 2017–2024 (USD Million)
Table 85 India: Market, By Mode of Purchase, 2017-2024 (USD Million)
Table 86 India: Market, By End User, 2017–2024 (USD Million)
Table 87 RoAPAC: Market, By Product, 2017–2024 (USD Million)
Table 88 RoAPAC: Market, By Mode of Purchase, 2017–2024 (USD Million)
Table 89 RoAPAC: Point-Of-Care Diagnostics Market, By End User, 2017–2024 (USD Million)
Table 90 RoW: Market, By Region, 2017–2024 (USD Million)
Table 91 RoW: Market, By Product, 2017–2024 (USD Million)
Table 92 RoW: Market, By Mode of Purchase, 2017–2024 (USD Million)
Table 93 RoW: Market, By End User, 2017–2024 (USD Million)
Table 94 Latin America: Market, By Product, 2017–2024 (USD Million)
Table 95 Latin America: Market, By Mode of Purchase, 2019–2024 (USD Million)
Table 96 Latin America: Market, By End User, 2017–2024 (USD Million)
Table 97 Middle East & Africa: Market, By Product, 2017–2024 (USD Million)
Table 98 Middle East & Africa: Market, By Mode of Purchase, 2017–2024 (USD Million)
Table 99 Middle East & Africa: Market, By End User, 2017–2024 (USD Million)


List of Figures (31 Figures)

Figure 1 Research Methodology Steps
Figure 2 Research Design
Figure 3 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 4 Research Methodology: Hypothesis Building
Figure 5 Data Triangulation
Figure 6 Point-Of-Care Diagnostics Market, By Product, 2019 vs. 2024 (USD Million)
Figure 7 Market, By Mode of Purchase, 2019 vs. 2024
Figure 8 Market Share, By Platform, 2019 vs. 2024
Figure 9 Market, By End User, 2019 vs. 2024
Figure 10 Market, By Region
Figure 11 Growing Government Support is Driving the Adoption of POC Devices Across the Globe
Figure 12 Professional Diagnostic Centers Segment Dominated the POC Diagnostics Market in 2018
Figure 13 Glucose Monitoring Kits Segment to Dominate the POC Diagnostics Market During the Forecast Period
Figure 14 Prescription-Based Testing Kits to Dominate the POC Diagnostics Market During the Forecast Period
Figure 15 North America to Register the Highest Cagr During the Forecast Period
Figure 16 POC Diagnostics Market: Drivers, Restraints, Opportunities, and Challenges
Figure 17 Point-Of-Care Diagnostics Market: Growth Forecast, By Region (2019–2024)
Figure 18 North America: Market Snapshot
Figure 19 APAC: Market Snapshot
Figure 20 Roche Diagnostics Held the Leading Position in the Market in 2018
Figure 21 Vendor Dive: Evaluation Overview
Figure 22 Abbott Laboratories: Company Snapshot
Figure 23 BD: Company Snapshot
Figure 24 Chembio Diagnostics: Company Snapshot
Figure 25 Danaher Corporation: Company Snapshot
Figure 26 Johnson & Johnson: Company Snapshot
Figure 27 Roche Diagnostics: Company Snapshot
Figure 28 Siemens Healthineers Group: Company Snapshot
Figure 29 EKF Diagnostics: Company Snapshot
Figure 30 Quidel: Company Snapshot
Figure 31 Trinity Biotech: Company Snapshot

The study involved four major activities in estimating the current size of the point-of-care diagnostics market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.

Secondary Research

In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Businessweek, and Factiva) were referred to in order to identify and collect information for this study.

Primary Research

The market comprises several stakeholders, such as manufacturers of point-of-care diagnostic systems, clinical research organizations (CROs), clinical laboratories, and hospitals. The demand side of this market is characterized by the global rise in the prevalence of infectious diseases. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. Following is the breakdown of primary respondents:

Point-of-Care Diagnostics market, by Region, 2022 (USD Billion)

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the point-of-care diagnostics market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry and markets have been identified through extensive secondary research.
  • The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes.
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

Data Triangulation

After arriving at the overall market size-using the market size estimation processes as explained above-the market was split into several segments and subsegments. In order to complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the market.

Report Objectives

  • To define, describe, and forecast the global point-of-care diagnostics market by product, mode of purchase, platform, end user, and region
  • To provide detailed information regarding the major factors influencing market growth (drivers, restraints, opportunities, and industry-specific challenges)
  • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the total market
  • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To provide a five-year forecast for various segments of the market in terms of revenue with respect to the four main regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa
  • To strategically profile the key players and comprehensively analyze their market shares and core competencies                              
  • To track and analyze competitive developments such as product launches; agreements, partnerships, collaborations, and joint ventures; and mergers and acquisitions in the market

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the point-of-care diagnostics market:

Product Analysis

  • Product matrix, which gives a detailed comparison of the product portfolios of the top five companies

Company Information

  • Detailed analysis and profiling of additional market players (up to 5)
Report Code
MD 2702
Published ON
Nov, 2019
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Point of Care Diagnostics Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

...

Digital Virtual Assistant - MarketsandMarkets

Home